Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 3/20 | 0.32 |
| ▸ | LRRK2 | Q5S007 | 2/20 | 0.31 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29364153 | 0.83 | GSK3B (0.46) | LRRK2SOS1 | |
| SCHEMBL25029067 | 0.83 | GSK3B (0.46) | LRRK2SOS1 | |
| SCHEMBL25029318 | 0.77 | NFATC1 (0.32) | LRRK2 | |
| SCHEMBL26180177 | 0.76 | IRAK4 (0.43) | — | |
| SCHEMBL25218789 | 0.74 | NFATC1 (0.32) | — | |
| SCHEMBL29364692 | 0.74 | NFATC1 (0.32) | — | |
| SCHEMBL25029103 | 0.73 | MBOAT4 (0.36) | LRRK2 | |
| SCHEMBL29364371 | 0.73 | MBOAT4 (0.36) | LRRK2 | |
| SCHEMBL26180189 | 0.73 | AAK1 (0.35) | LRRK2 | |
| SCHEMBL26180157 | 0.72 | GSK3B (0.41) | LRRK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11667624-B2 | Indole compounds as androgen receptor modulators | NIDO BIOSCIENCES, INC. (US) | 2023-06-06 | — | — | US | disclosed |
| US-11667624-B2 | Indole compounds as androgen receptor modulators | NIDO BIOSCIENCES, INC. (US) | 2023-06-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11667624-B2 | Indole compounds as androgen receptor modulators | AR, FSHR, ADRB3 | MAPK1 3135/4885LRRK2 199/4885SOS1 4568/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.